<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>19</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Arif Khan</style></author><author><style face="normal" font="default" size="100%">Imran Pervez</style></author><author><style face="normal" font="default" size="100%">Anand Sharma</style></author><author><style face="normal" font="default" size="100%">Parikshit Bansal</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">TRIPS impact on R&amp;D- Facts, Facets and Implications for Indian Pharma Industry</style></title></titles><dates><year><style  face="normal" font="default" size="100%">2005</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">www.expresspharmapulse.com/20050224/trips01.shtml</style></url></web-urls></urls><notes><style face="normal" font="default" size="100%">Article specially commended by Industry Representative (Overseas Healthcare Pvt.Ltd., India)</style></notes></record></records></xml>